Literature DB >> 2089114

Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.

A Colzi1, F d'Agostini, R Kettler, E Borroni, M Da Prada.   

Abstract

The effect of reversible inhibitors of the monoamine oxidase type A (MAO-A), moclobemide (Aurorix) and Ro 41-1049 (20 mg/kg i.p. each), as well as of reversible inhibitors of the MAO type B (MAO-B), Ro 19-6327 (1 mg/kg i.p.), on the outflow of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) was studied in the rat by transstriatal microdialysis. Reversible MAO-A inhibitors markedly increased the output of DA and concomitantly decreased the output of DOPAC and HVA. These effects were absent with the highly selective MAO-B inhibitor Ro 19-6327.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2089114     DOI: 10.1007/978-3-7091-9113-2_9

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  10 in total

1.  Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.

Authors:  T Ilani; I Lamensdorf; J P Finberg
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 2.  The catecholaldehyde hypothesis: where MAO fits in.

Authors:  David S Goldstein
Journal:  J Neural Transm (Vienna)       Date:  2019-12-05       Impact factor: 3.575

3.  Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior.

Authors:  M J Heeringa; F d'Agostini; P DeBoer; M DaPrada; G Damsma
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.

Authors:  A Colzi; F d'Agostini; A M Cesura; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine.

Authors:  A Holt; G B Baker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

Review 6.  A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.

Authors:  R B Rothman; J R Glowa
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

7.  Quantitative distribution of rat brain monoamine oxidase A by [14C]clorgyline autoradiography.

Authors:  Y Kondoh; M Murakami; W Yin; S Mizusawa; H Nakamichi; K Nagata
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

8.  Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.

Authors:  Kirsten E Culver; Henry Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

Review 9.  The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.

Authors:  David S Goldstein
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

10.  Novel Diels-Alder Type Adducts from Morus alba Root Bark Targeting Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases.

Authors:  Pradeep Paudel; Se Eun Park; Su Hui Seong; Hyun Ah Jung; Jae Sue Choi
Journal:  Int J Mol Sci       Date:  2019-12-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.